CMV
Clinical trials for CMV explained in plain language.
Never miss a new study
Get alerted when new CMV trials appear
Sign up with your email to follow new studies for CMV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to knock out CMV faster in lung transplant patients
Disease control Recruiting nowThis study tests whether adding a drug called letermovir to the usual antiviral treatment helps clear CMV infection faster in people who have received a lung transplant. About 40 participants with active CMV will receive either letermovir or a placebo alongside standard care. The…
Matched conditions: CMV
Phase: PHASE4 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New hope for kidney transplant patients: antibody shot may stop dangerous virus
Prevention Recruiting nowThis study tests whether an antibody treatment called CMVIG can prevent CMV infection in kidney transplant patients. Researchers will measure antibody levels in 30 adults who are switching to a new anti-rejection drug. The goal is to see if CMVIG is safe and effective at blocking…
Matched conditions: CMV
Phase: PHASE1, PHASE2 • Sponsor: University of Minnesota • Aim: Prevention
Last updated May 14, 2026 12:04 UTC
-
New hope for transplant patients: extended drug course may stop dangerous virus
Prevention Recruiting nowThis study tests whether taking letermovir for a longer time (up to 28 weeks) can prevent cytomegalovirus (CMV) infection in 330 high-risk Chinese adults who have received a stem cell transplant. CMV is a common and serious complication in these patients because their immune syst…
Matched conditions: CMV
Phase: NA • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Prevention
Last updated May 11, 2026 20:39 UTC
-
Scientists hunt for hidden immune flaws behind severe virus cases
Knowledge-focused Recruiting nowThis study looks for immune system problems that might make some people get very sick from viruses like herpes, chickenpox, or HPV. Researchers will test blood and skin samples from up to 600 people who have had severe viral infections, along with their relatives. The goal is to …
Matched conditions: CMV
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC